Companies: 10,795·Total market cap: $144.5T
AstraZeneca PLC

AstraZeneca PLC

AZNCFOTCHealthcare
$189.90
$-2.60(-1.35%)
Market Cap$294.4B
P/E Ratio—
52W High$209.48
52W Low$122.26
Overview
Stock ranking:Drug Manufacturers - General·Healthcare·View All Market Cap Rankings →

AstraZeneca PLC (AZNCF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AZNCF · as of Jun 8, 2026

Key Statistics

EPS (TTM)$6.59azncf eps ttm · azncf earnings per shareEarnings history
PE Ratio (TTM)28.8×azncf pe ratio ttm · azncf price to earningsPE Ratio deep dive
Revenue (TTM)$58.7Bazncf revenue ttm · azncf annual revenueFull revenue history
Dividend Yield1.31%does azncf pay dividends · azncf dividend yieldDividend history
Shares Outstanding1.55Bazncf shares outstanding · azncf floatShares outstanding history
Next EarningsTBAazncf earnings date · azncf next earningsEarnings history

Explore AstraZeneca PLC Data

azncf stock data · financials
Market Cap$294.4Bazncf market cap · azncf valuation
Analyst Forecast$— · Buy
Dividends1.31%does astrazeneca plc pay dividends · azncf dividend yield
Revenue$58.7B+8.63%astrazeneca plc annual revenue · azncf revenue
EarningsEPS $6.60+45.37%azncf earnings · azncf eps
PE Ratio28.8×azncf pe ratio · azncf price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$58.74B▲ +8.63% YoY
202320242025
astrazeneca plc revenue · azncf revenue 2025
FY 2025Net Income$10.22B▲ +45.34% YoY
202320242025
astrazeneca plc net income · azncf profit 2025
FY 2025EPS$6.60▲ +45.37% YoY
202320242025
azncf eps · astrazeneca plc earnings per share 2025
TTM:Revenue: $58.74BNet Income: $10.30BEPS: $6.59View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy36 analystsis azncf a buy · azncf analyst rating
Strong Buy
1
Buy
16
Hold
15
Sell
4
Strong Sell
0
12-Month Price Target
$—Low
$189.90Current
$—Avg Target
$—High
azncf price target · azncf 12 month forecast

Total: 36 · Buy rate: 47.2%

Stock Performance

Full History
1D+0.00%
1W-7.25%
1M-1.35%
3M+2.38%
YTD+3.95%
1Y+44.62%
5Y+91.20%

About AstraZeneca PLC

CEOPascal Claude Roland Soriot
IPO DateFeb 13, 2009
Employees94,300
CountryGB
Websiteastrazeneca.com

AstraZeneca PLC functions as a global biopharmaceutical enterprise, committed to the entire process of pharmaceutical innovation, spanning from the initial discovery and development stages to the manu…

Drug Manufacturers - GeneralHealthcareOTCGB

what is astrazeneca plc · azncf stock overview · astrazeneca plc company profile · who is astrazeneca plc ceo · azncf OTC · astrazeneca plc headquarters · astrazeneca plc business segments

About Stock Overview & Key Data

AstraZeneca PLC (AZNCF) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Feb 13, 2009. As of the latest trading session, AZNCF stock price is $189.90, with a market capitalization of $294.4B. The stock has returned +44.62% over the past 12 months and +3.95% year-to-date.

According to 36 Wall Street analysts, the consensus rating for AstraZeneca PLC stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, AstraZeneca PLC reported revenue of $58.7B and net income of $10.2B. For detailed data — including AstraZeneca PLC revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, AstraZeneca PLC (AZNCF) stock price is $189.90. The stock is traded on OTC under the ticker symbol AZNCF. The 52-week range is $122.26 – $209.48.

AZNCF stock priceAZNCF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice